Investment9 April 2026 at 01:31 pm
Fredun Pharmaceuticals Allots 40,000 Equity Shares to Promoter upon Conversion of Warrants
AI Summary
Fredun Pharmaceuticals Ltd. has allotted 40,000 equity shares to promoter Mrs. Daulat Nariman Medhora upon conversion of warrants. The warrants were allotted on preferential basis on December 29, 2025, and the warrant holders have paid the balance consideration of ₹ 3,75,00,000/-. The allotment of equity shares shall be made in dematerialized form and will rank pari passu with the existing equity shares of the company.
Key Highlights
- Fredun Pharmaceuticals allots 40,000 equity shares to promoter
- Allotment upon conversion of warrants issued on preferential basis
- Warrant holders have paid balance consideration of ₹ 3,75,00,000/-
- Allotment of equity shares to be made in dematerialized form
- Equity shares to rank pari passu with existing equity shares
FREDUNPharmaceuticals
Fredun Pharmaceuticals LtdPrice Impact